Boston Scientific's Restructuring: A Cost-Cutting Gambit Amidst Deeper MedTech Headwinds

Related Articles

Boston Scientific Insiders Bet on a Long-Term Rebound Amidst Near-Term Headwinds

2 months ago

Why is Boston Scientific Acquiring Penumbra

7 months ago

What Does Paloma Partners' Divestment Mean for Core Scientific

7 months ago

What's Brewing for Boston Beer's Q4 Earnings

7 months ago

Category

You may also like

Stock News•1 months ago

Boston Scientific Leans on Acquisitions to Drive Long-Term Growth

Boston Scientific is leaning on acquisitions to expand into high-growth markets, with the Penumbra deal adding a major thrombectomy opportunity. The strategy aims to drive long-term growth, though no ...

BSX

Share

Stock News•2 months ago

Boston Scientific unveils new restructuring plan, expects job cuts

Boston Scientific announced a new company-wide restructuring plan approved by its board, expecting job cuts to reduce costs and position for future growth, per a Monday regulatory filing.

BSX

Share

Stock News•3 months ago

Boston Scientific: The Time Has Come To Catch This Falling Knife

Boston Scientific shares fell ~60% from a September 2025 high of $109.50 to ~$45.00, after the company cut its FY26 organic growth guidance to 6.5%-8.0% in Q1-26 earnings.

BSX

Share